Investigating the effect of vesicle therapy and cell therapy in intrauterine adhesions

Not Applicable

• Conditions: Asherman syndrome (intrauterine adhesions).; Complication associated with artificial fertilization, unspecified; N98.9

• Registration Number: IRCT20160422027520N23
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 March 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: 20

Inclusion Criteria

Women aged 20 to 44 whose disease has been proven
be in low to medium stages of the disease
have no blood pressure, diabetes, cardiovascular diseases and other underlying problems
Not during menstruation or menopause
Their cycles during treatment should preferably be close to each other
have filled out the informed consent form
Do not have any history of immunotherapy

Exclusion Criteria

Patients under 20 years old and over 44 years old
Patients who themselves or their spouses have abnormal karyotype or genetic and chromosomal disorders
Patients with coagulation problems
Patients who have an underlying chronic disease and have to take special drugs
Patients whose HIV, HCV or HBV test results are positive
Patients who have a history of asthma and allergies to certain drugs
Patients with intrauterine anomalies

Study & Design

• Study Type: interventional
• Study Design: Not specified